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On some occasions, mutations of a gene cause different
syndromes that may have similar phenotypes. For
example, mutations of the MITF gene cause Waardenburg
syndrome type 2 (Tassabehji et al, 1994; Nobukuni et al,
1996) as well as Tietz syndrome (Smith et al, 1997). On
other occasions, mutations of different genes cause an
identical syndrome. Molecular analyses of these genes
may provide a good opportunity to not only understand
such syndromes themselves but also the biologic aspects
of cells relevant to these syndromes. By analyzing the
genes for Waardenburg syndrome, we showed that PAX3,
We have previously described transgenic mice,named VGA-9, with an insertional mutation(Tachibana et al, 1992). Phenotypes of homo-zygotes of these mice, i.e., white coat color,microphthalmia, and hearing impairment, are
reminiscent of Waardenburg syndrome (WS), whose major symptoms
are leucodermia, white forelock, heterochromia irides, and hearing
impairment. Skin, hair follicle, eye, and cochlea of mammals contain
melanocyetes. Thus, the major symptoms of WS individuals and
VGA-9 mice may be due to lack of melanocytes in these tissues. We
examined VGA-9 with special interest in their melanocyte pathology.
Indeed, morphologic analysis revealed that homozygous VGA-9 are
lacking in melanocytes in affected tissues, i.e., skin, eye, and cochlea.
Cochleae of mammals contain melanocytes as intermediate cells of
the stria vascularis, which play an important role for production/
maintenance of endolymph and thus for hearing function. Lack of
strial intermediate cells caused degeneration of not only stria vascularis
but also, successively, the organ of Corti that contains mechano-
receptor hair cells. Thus, all of the revealed phenotypes of VGA-9 and
WS2 can be explained by a lack of melanocytes.
These observations are consistent with the notion that the genes
responsible for VGA-9 and WS2 are involved in melanocyte
differentiation/survival. Intriguingly, the murine microphthalmia (mi)
gene, which is mutated in VGA-9 and in a series of classical ‘‘micro-
phtahlmia’’ mice (Hodgkinson et al, 1993; Steingrı´msson et al, 1994),
and its human homolog MITF (microphthalmia-associated transcription
factor) gene, which is assigned to chromosome 3p14.1-p12.3 (Tachibana
et al, 1994) and is mutated in WS2 (Tassabehji et al, 1994; Nobukuni
et al, 1996), encode a protein with basic-helix-loop-helix-leucine-
zipper structure. Proteins with such a structure are often transcription
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the gene responsible for Waardenburg syndrome type 1,
regulates MITF, the gene responsible for Waardenburg
syndrome type 2. Such epistatic relationships have been
shown between other genes related to Waardenburg
syndrome, and likely to construct a cascade. This paper
proposes such a cascade, one that involves genes for
PAX3, MITF, human MyoD, MYF5, c-MET, c-KIT,
tyrosinase, TRP-1, human QNR-71, SOX10, EDNRB,
and EDN3. Key words: EDNRB/MITF/PAX3/SOX10.
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factors that are involved in cell differentiation. To test the hypothesis
that MITF is involved in melanocyte differentiation, we transfected
NIH-3T3 fibroblasts with a MITF cDNA inserted in an expression
vector (Tachibana et al, 1996; Tachibana, 1997), and the transfection
converted NIH-3T3 cells into cells with melanocytic characteristics.
These cells were dendritic as melanocytes and expressed tyrosinase,
tyrosinase-related protein 1 (TRP-1), and TRP-2, enzymes that
catalyze melanin synthesis, although these cells did not synthesize
melanin probably due to mutations of the tyrosinase gene in NIH-
3T3 cells.
Besides MITF, four genes have been shown to be responsible for
WS. PAX3, the first identified gene for WS, is a human homolog of
mouse Pax-3, whose mutations were found in splotch mice. Mutations
of PAX3 were originally found in WS1 families, whose symptoms
include distopia canthorum (lateral displacement of inner canthi of
eyes) in addition to the previously mentioned major WS symptoms.
Next, PAX3 mutations were found in families of WS3, whose symptoms
include deformity of upper limbs besides the major symptoms. Because
distopia canthorum and upper limb deformity cannot be explained by
melanocytes anomaly, and because PAX3 encodes a transcription factor
with paired domain and homeodomain, it is likely that PAX3 is
involved in differentiation of cells other than melanocytes. On the
other hand, it has not been explained how PAX3 mutations cause
symptoms resulting from melanocyte anomaly in WS1. Two possibilities
were considered: the first is that PAX3 directly differentiates melano-
cytes; the second is that PAX3 differentiates melanocytes through
transactivation of MITF. Expression of PAX3/Pax-3 in melanocytes is
consistent with both of these possibilities; however, we preferred the
second possibility because Pax-3 is expressed earlier and more widely
than mi in neural crest. This paper describes how we proved our
hypothesis that PAX3 transactivates the MITF gene, and failure of the
transactivation due to PAX-3 mutations causes WS1 symptoms related
to melanocytes anomaly. Other epistatic relationships of WS genes
and protein–protein interaction between their gene products is also
discussed.
MATERIALS AND METHODS
Cloning of the MITF promoter The approximately 2.3 kb promoter region
of MITF was isolated from a P1 clone containing the first exon of the MITF
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Figure 1. PAX3 transactivates the MITF promoter. The numbers shown at each reporter constructs denote the boundaries upstream and downstream of the
initiation site (11). (a) The MITF promoter is efficiently activated in melanoma cells (624-mel) but not in HeLa cells. (b) Co-transfected PAX3 cDNA transactivates
the promoter constructs in HeLa cells. (c) The region between position –263 and –238 of the MITF promoter is critical for the promoter activity. Deletion and
mutation of this region results in loss of promoter activity. Eight copies of this region fused to the basal MITF promoter is also activated. (Reproduced from
Watanabe et al, 1998 with permission.)
gene. This region was cloned into the luciferase reporter plasmid pGL2-
Basic and termed pMITF-2256. Deletion constructs pMITF-382, pMITF-263,
pMITF-238, pMITF-382del(260–245), and pMITF-382mut were generated
by restriction enzymes or polymerase chain reaction (PCR)-based method.
Cloning of PAX3 cDNA Human PAX3 cDNA containing a Kozak sequence
and an entire coding region was generated by reverse transcriptase-polymerase
chain reaction (RT-PCR) using RNA from melanoma cells. Three mutations
of PAX3 cDNA were designed from reported WS1 mutations and generated
by site-directed mutagenesis. The wild-type or mutant PAX3 cDNA were
cloned into an expression vector pCEV27.
Reporter assay Approximately 60% confluent cells seeded 1 d before in six-
well plates were cotransfected using LipofectAmine (Gibco BRL) reagents as
the reporter plasmid (0.5 µg), effector plasmid (0.5 µg), and β-galactosidase
expression vector PCH110 (0.2 µg, Pharmacia). After 24 h, cells were lyzed
and assayed for luciferase activity.
Electrophoretic mobility shift assay (EMSA) Wild-type and mutated
PAX3 proteins were derived from in vitro transcription/translation reactions.
Equivalent amounts of proteins, as determined by [35S]-methionine labeling,
were incubated with end-labeled oligonucleotide of the MITF promoter
sequence from nucleotide –265 to –236 (approximately 4 3 104 cpm). After
incubation the reaction mixture was loaded on a polyacrylamice gel and then run.
Details of these procedures were fully described in the original paper
(Watanabe et al, 1998).
RESULTS AND DISCUSSION
Approximately 2.3 kb of the MITF 59-upstream region (nucleotides–
2256 to 196; transcription site 1) was cloned from a P1 library
(GenBank accession number: BankIt: 153821; AF034755). This region
and a shorter region (nucleotides –382 to 196) fused to the luciferase
gene were activated strongly when transfected in human melanoma
cells but not in HeLa cells, as judged by luciferase activity (Fig 1a).
We thought the difference was due to the fact that PAX3 is expressed
in melanoma cells but not in HeLa cells. Consistent with this notion,
ectopic expression of PAX3 in HeLa cells transactivated the MITF
promoter (Fig 1b). Furthermore, we found a consensus sequence for
binding to the homeodomain (ATTAAT) and paired domain (GGAAC)
between position –263 and –238. In vitro translated/transcribed PAX3
protein was found to bind the promoter sequence around this consensus
sequence specifically as judged by EMSA (data not shown). Promoter
constructs that do not contain this sequence were not activated in
melanoma cells (Fig 1c).
Next we examined the effect of PAX3 mutations observed in WS1
on MITF transactivation using reporter assay and EMSA. We selected
three PAX3 mutations that usually occur in the paired domain or
homeodomain (Fig 2); Pro50Leu, Arg271Gly, Try266Cys. All of these
PAX3 mutations failed to bind or transactivate the MITF promoter
(Fig 3). These findings show that MITF is a target gene of PAX3 and
provide a molecular basis for the hypopigmentation and hearing
impairment of individuals with WS1.
Pax-3 deficient splotch mice (Bober et al, 1994) and PAX3 deficient
WS type 3 (WS3) individuals (Hoth et al, 1993) display limb muscle
hypoplasia. Pax-3 plays an important role in appropriate migration of
myoblasts to the limb bud (Bober et al, 1994; Goulding et al, 1994;
Williams and Ordahl, 1994). Thus, PAX3/Pax-3 likely regulates genes
involved in muscle differentiation. Product of an oncogene, c-met, is
also required for limb muscle development (Bladt et al, 1995), and this
gene encodes the receptor for hepatocyte growth factor of a receptor
tyrosine kinase family (Bottaro et al, 1991). Epstein et al (1996) revealed
that c-met is a target gene of Pax-3. First, they showed reduction of c-
met expression in splotch mice. Next, they showed Pax3 can stimulate
c-met expression in cultured cells. They found putative Pax3 DNA-
binding sites in the human c-MET promoter. Muscle differentiation
and development are dependent on myogenic genes, MyoD, Myf5,
MyoD, and myogenin. Recently, it was shown that infection of
embryonic tissue with a retrovirus encoding Pax-3 is sufficient to
induce expression of MyoD, Myf-5, and myogenin (Maroto et al, 1997).
Consistent with this finding, investigation of splotch/Myf-5–/– double
mutant revealed that MyoD acts genetically downstream of Pax-3 and
Myf-5 (Tajbakhsh et al, 1997).
Our previous finding of tyrosinase and TRP-1 induction in
permanent MITF transfectants (Tachibana et al, 1996; Tachibana, 1997)
implies that genes for these enzymes are downstream genes of MITF.
To support this notion it was shown that promoters of the tyrosinase
and TRP-1 genes were transactivated by MITF through binding with
an M-box in these promoters (for review see Shibahara et al, 1998).
In contrast, the promoter of the TRP-2 gene was not transactivated
by MITF despite the existence of an M-box in the promoter
(Yasumoto et al, 1997). Consistent with this finding, we were able
to induce melanocytic characteristics by MITF in fibroblasts that
constitutively express TRP-2 but not in other fibroblasts that do not
express it (Tachibana et al, 1994). Others found that TRP-2 expression
did not depend on mi in retinal pigment cell (Opdecamp et al, 1997).
The c-kit promoter is transactivated by mi, and overexpression of
mi rescues the low c-kit expression in mast cells lacking wild-type mi
(Tsujimura et al, 1996). Mi upregulated c-Kit expression in melanocyte
precursor cells of neural crest, although onset of c-kit was independent
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Figure 2. Diagram of the PAX3 gene
showing location of mutations detected.
Each box indicates an exon. Numbers in
parentheses denote the numbers of deleted
nucleotides. Non-truncating mutations are
expected to encode a full-length PAX3 with
a substitution of an amino acid at the paired
or homeodomain. S, splice-site mutation
(modified from Tassabehji et al, 1995;
mutations cited by Baldwin et al, 1995;
Tassabehji et al, 1995; Watanabe et al, 1998
are shown).
Figure 3. Mutant PAX3 failed to bind and transactivate the MITF promoter. (a) EMSA: PAX3[P50 L] (predicting the substitution of an amino acid in the paired
domain) and PAX3[R271G]/PAX3[W266C] (predicting the substitution of an amino acid in the homeodomain) fail to bind the consensus sequence (ATTAATAC-
TACTGGAAC) in the MITF promoter sequence, whereas wild-type PAX3 does bind the sequence. Arrowheads identify higher (H) and lower (L) DNA-protein
complexes, and the free probe (F). The higher complex (H) is sequence specific and contains PAX3 protein, whereas the lower complex (L) is not sequence specific and
does not contain PAX3 (not shown). (b) Reporter assay: Co-transfection of mutated PAX3 cDNA, designed from mutations found in WS1, failed to transactivate the
MITF promoter, whereas wild-type PAX3 cDNA did transactivate. (Reproduced from Watanabe et al, 1997 with permission.)
of mi (Opdecamp et al, 1997). Stimulation of c-Kit receptor in
melanoma cells activated MAP kinase, which in turn phosphorylated
Mi by recruiting p300/CBP and consequently upregulated the
tyrosinase gene (Hemesath et al, 1998; Price et al, 1998). These
findings suggest that c-kit is a downstream gene of mi and interaction
of Mi and that c-Kit is crucial for melanocyte development. Mutaions
of c-KIT cause phenotypes similar to WS: piebaldism associated with
deafness in human (Spitz and Beighton, 1998). Another gene shown
to be downstream of mi is the quail QNR-71 gene, which is expressed
specifically in pigment layers and encodes a protein homologous to
melanosomal matrix protein. The promoter of this gene is transactivated
by two b-HLHZip proteins, i.e., Mi and c-MYC (Turque et al, 1996).
WS associated with Hirschprung disease, i.e., aganglionic megacolon,
is classified as WS type 4 (WS4). Mutations of three genes have been
identified in WS4: genes for endothelin-B receptor or endothelin 3
and the SOX10 gene. Disruption of the murine endothelin-3 (Edn3)
gene and the endothelin-receptor (Ednrb) gene results in aganglionic
megacolon and spotted coat color in mice (Baynash et al, 1994; Hosoda
et al, 1994). Human mutations of EDN3 (Edrey et al 1996; Hofstra
et al, 1996) and EDNRB (Puffenberger et al, 1994) are associated with
WS4 families. Mutations of murine Sox10 or human SOX10, encoding
a transcription factor with the HMG DNA-binding motif, were found,
respectively, in Dom mice with megacolon (Pingault et al, 1998) and
WS4 families (Southard-Smith et al, 1998). Thus, interaction of
EDN3/Edn3 and EDNRB/Ednrb, and activation of SOX10/Sox10,
seem to be essential for development of epidermal melanocytes and
enteric neurons; however, the question of how these gene products
fit in the cascade of WS genes remains to be answered. While Edn3
enhanced the number of melanocytes in wild-type neural crest cultures
(Reid et al, 1996), it did not do so in those from mi-mutated mice
(Opdecamp et al, 1997). These findings are consistent with the notion
that Endrb is the downstream of mi, and, consequently Endrb is not
expressed in neural crest cells of mi-mutant mice. Because Ednrb
positive cells are expressed in migrating neural crest cells of 10.5-d.p.c.
Sox10Dom/Sox10Dom embryos (Southard-Smith et al, 1998), Ednrb seems
to be independent of Sox10. Furthermore, since Edrnb-and TRP-1-
VOL. 4, NO. 2 SEPTEMBER 1999 WAARDENBURG SYNDROME GENE CASCADE 129
Figure 4. A cascade of genes and/or their products related to
Waardenburg syndrome. Ovals represent transcription factors, and
rectangles represent other types of proteins; those responsible for WS are in
black. PAX3, human MyoD, MYF5, and c-MET are involved in myocyte
differentiation/proliferation, whereas PAX3, MITF, SOX10, c-KIT, tyrosinase,
TRP-1, human QNR-71, EDNRB, and EDN3 are involved in melanocyte
differentiation/proliferation. It is unlikely that SOX10 regulates EDNRB, and
thus the downstream genes of SOX10 remains to be elucidated.
positive cells were virtually absent in neural crest of the 11.5-d.p.c
embryos (Southard-Smith et al, 1998), Sox10 seems to determine the
neural crest cell fate.
To summarize, three transcription factor genes, PAX3, MITF, and
SOX10, have been shown to be responsible for WS. By epistatic
relationship, the PAX3 gene most likely regulates the human MyoD,
MYF5, and c-MET genes, whereas the MITF gene regulates genes for
c-KIT, tyrosinase, TRP-1, and human QNR-71. In addition, we
determined the epistatic relationship of PAX3 and MITF (Watanabe
et al, 1998). Further studies will determine whether there is an epistatic
relationship between SOX10 and MITF or PAX3. Completion of
cascade-like network among genes and/or gene products related to
WS (Fig 4) will help us understand the mechanism of the manifestation
of WS symptoms.
I thank my colleagues Drs A Watanabe and K Takeda, without whose help the present
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